REFERENCES
- Li FP, Fraumeni JF Jr. Soft-tissue sarcomas, breast cancer, and other neoplasm. A familial syndrome? Ann Intern Med. 1969;71:747–752.
- Li FP, Fraumeni JF Jr, Mulvihill JJ, . A cancer family syndrome in twenty-four kindred. Cancer Res. 1988;48:5358–5362.
- Li FP, Garber JE, Friend SH, . Recommendations on predictive testing for germ line p53 mutations among cancer-prone individuals. J Natl Cancer Inst. 1992;84:1156–1160.
- Li YJ, Sanson M, Hoang-Xuan K, . Incidence of germ-line p53 mutations in patients with gliomas. Int J Cancer. 1995;64:383–387.
- Olivier M, Goldgar DE, Sodha N, . Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. Cancer Res. 2003;63:6643–6650.
- Birch JM, Hartley AL, Tricker KJ, . Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res. 1994;54:1298–304.
- Eeles RA. Germ line mutations in the TP53 gene [review]. Cancer Surv. 1995;25:101–124.
- Malkin D, Li FP, Strong LC, Fraumeni JF, . Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasm. Science. 1990;250:1233–1238.
- Kleihues P, Schauble B, Zur HA, . Tumors associated with p53 germline mutations: a synopsis of 91 families. Am J Pathol. 1997;150:1–13.
- Wong SS, Lozano G, Gaff CL, . Novel p53 germ line mutation in a patient with Li-Fraumeni syndrome. Intern Med J. 2003;33:621–623.
- Bendig I, Mohr N, Kramer F, Weber BH. Identification of novel TP53 mutations in familial and sporadic cancer cases of German and Swiss origin. Cancer Genet Cytogenet. 2004;154:22– 26.
- Sandrini R, Ribeiro RC, DeLacerda L. Childhood adrenocortical tumors. J Clin Endocrinol Metab. 1997;82:2027–2031.
- Michalkiewicz E, Sandrini R, Figueiredo B, . Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry. J Clin Oncol. 2004;22:838–845.
- Abramson DH, Beaverson K, Sangani P, . Screening for retinoblastoma: presenting signs as prognosticators of patient and ocular survival. Pediatrics. 2003;112:1248–1255.
- Lalloo F, Varley J, Ellis D, , and the early onset breast cancer study Group. Family history is predictive of pathogenic mutations in BRCA1, BRCA2 and TP53 with high penetrance in a population based study of very early onset breast cancer. Lancet. 2003;361:1101–1102.
- Moule RN, Jhavar SG, Eeles RA. Genotype phenotype correlation in Li-Fraumeni syndrome kindreds and its implications for management. Fam Cancer. 2006;5:129–133.
- Varley JM, McGown G, Thorncroft M, . Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families. Cancer Res. 1997;57:3245–3252.
- Birch JM, Alston RD, McNally RJQ, . Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene. 2001;20:4621–4628.
- Varley JM, Evans DGR, Birch JM. Li-Fraumeni syndrome—a molecular and clinical review. Br J Cancer. 1997;76:1–14.
- Evans DGR, Morrison P. The ethical and insurance issues in testing for cancer predisposition genes. In: Eeles R, Ponder B, Easton D, Eng C, Horwich A, eds. Genetic Predisposition to Cancer. 2nd ed. London: Chapman and Hall; 2004:414–423.
- Evans DGR, Maher ER, Macleod R, . Uptake of genetic testing for cancer predisposition. J Med Genet. 1997;34:746–748.
- Evans DG, Lunt P, Clancy T, Eeles R. Childhood predictive genetic testing for Li-Fraumeni syndrome. Fam Cancer. 2009;9:65–69.
- Chompret A, Brugieres L, Ronsin M, . P53 germ line mutations in childhood cancers and cancer risk for carrier individuals. Br J Cancer. 2000;82:1932–1937.
- Varley JM. Germline TP53 mutations and Li-Fraumeni syndrome. Hum Mutat. 2003;21:313–320.